VIII Symposium "Design, Obtaining and Development of Drugs" "SICF"

VIII International Symposium on Chemistry and Pharmaceutical Sciences

SICF

VIII Symposium "Design, Obtaining and Development of Drugs"

alzheimer’s disease; mri contrast agent; gadolinium(iii) oxide nanoparticles; dota; amylovis® ×

Book your talks

Plan your experience by adding your favorites talks to your wishlist

Tuesday 14
November 2023

Gadolinium(III) based contrast agents with potential applications in the early detection of Alzheimer's disease
M. Sc. Gabriel Rafael Guerrero Porras

alzheimer’s disease; mri contrast agent; gadolinium(iii) oxide nanoparticles; dota; amylovis® enfermedad de alzheimer; agentes de contrastes para rmi; nanopartículas de óxido de gadolinio(iii); dota; amylovis®

Instituto Finlay de Vaunas

EAA Heriberto Duquesne

Gold

Álamo Empresa Cárnica

Silver

BIOCUBAFARMA

Centro de Análisis del Ciclo de Vida (CADIS)